Viscoelastic Intragermal Implant Based on Hyaluronic Acid ESTELINE

Viscoelastic Intragermal Implant Based on Hyaluronic Acid ESTELINE

ESTELINE

I. ESTELINE Vita 18 mg/ml

Composition:
Hyaluronic acid 18 mg/ml (sodium hyaluronate, produced by HTL S.A.S., France)

• Syringe with plunger stroke limiter, 1.0 ml
• Sterile single-use needle 0.3 mm x 13 mm (30G) - 2 pcs.
• Instructions for use
• Labels - 3 pcs.

II. ESTELINE Voluma 23 mg/ml

Composition:
Hyaluronic acid 23 mg/ml (sodium hyaluronate, produced by HTL S.A.S., France)

• Syringe with plunger stroke limiter, 1.0 ml
• Sterile single-use needle 0.4 mm x 12.7 mm (27G) - 2 pcs.
• Instructions for use
• Labels - 3 pcs.

III. ESTELINE Basic 23 mg/ml

Composition:
Hyaluronic acid 23 mg/ml (sodium hyaluronate, produced by HTL S.A.S., France)

• Syringe with plunger stroke limiter, 1.0 ml
• Sterile single-use needle 0.4 mm x 12.7 mm (27G) - 2 pcs.
• Instructions for use
• Labels - 3 pcs.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Viscoelastic Intragermal Implant Based on Hyaluronic Acid ESTELINE, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.